Paola Matteucci
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells.
Journal: Journal for immunotherapy of cancer
Published: May 08, 2021
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi.
Journal: Journal of geriatric oncology
Published: January 03, 2019
Cognitive decline in older long-term survivors from Non-Hodgkin Lymphoma: a multicenter cross-sectional study.
Journal: Journal of geriatric oncology
Published: December 18, 2018
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma.
Journal: Leukemia
Published: July 17, 2018
Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.
Journal: International journal of radiation oncology, biology, physics
Published: July 21, 2015
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 26, 2014
Predictors of CD34+ cell mobilization and collection in adult men with germ cell tumors: implications for the salvage treatment strategy.
Journal: Clinical genitourinary cancer
Published: September 12, 2013
Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 17, 2013
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis.
Journal: Bone marrow transplantation
Published: July 10, 2013
Detection of minimal residual disease in hematopoietic progenitor cell harvests: lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma.
Journal: American journal of blood research
Published: February 20, 2012
Phase II study of sorafenib in patients with relapsed or refractory lymphoma.
Journal: British journal of haematology
Published: January 16, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026